Stay updated on MAGE-A1 TCR T-cells + Atezolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MAGE-A1 TCR T-cells + Atezolizumab in Solid Tumors Clinical Trial page.

Latest updates to the MAGE-A1 TCR T-cells + Atezolizumab in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check46 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check53 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check68 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check75 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference1.0%
- Check104 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
Stay in the know with updates to MAGE-A1 TCR T-cells + Atezolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MAGE-A1 TCR T-cells + Atezolizumab in Solid Tumors Clinical Trial page.